Table 1.

Baseline characteristics, baseline PE risk, and PE outcomes in the Black population compared with the mostly White population

FactorLevelBlack (n = 115)Other races (n = 251)P value
Demographic characteristics     
Age, mean  60.5 (15.6) 62.0 (16.1) .42 
Gender Women 60 (52.2%) 117 (46.6%) .32 
Racial group Black 115 (100.0%) 0 (0.0%) <.001 
 White 0 (0.0%) 234 (93.2%) <.001 
 Hispanic 0 (0.0%) 9 (3.6%) .04 
 Asian 0 (0.0%) 2 (0.8%) .34 
 Native American 0 (0.0%) 0 (0.0%) 
 Other 0 (0.0%) 6 (2.4%) .1 
History of heart failure  23 (22.5%) 27 (12.3%) .018 
History of chronic lung disease  23 (22.8%) 41 (18.7%) .4 
History of cancer  19 (18.6%) 75 (33.8%) .005 
Smoking  21 (22.8%) 23 (11.6%) .013 
PE and treatment characteristics     
European Society of Cardiology Risk Low 10 (8.7%) 29 (11.6%) .45 
 Intermediate-low 19 (16.5%) 51 (20.3%)  
 Intermediate-high 56 (48.7%) 97 (38.6%)  
 High 15 (13.0%) 41 (16.3%)  
 Unknown 15 (13.0%) 33 (13.1%)  
Presence of right ventricular strain by CT or echocardiography  82 (82.0%) 177 (81.6%) .99 
 Unknown 15 (13.0%) 33 (13.1%)  
Systemic thrombolysis  6 (6.6%) 16 (8.0%) .67 
Catheter directed therapy  47 (51.1%) 109 (51.7%) .93 
PE outcomes     
Length of hospital stay, median  13.8 (12.1) 14.3 (15.7) .78 
90-day major bleeding  8 (9.2%) 8 (4.3%) .11 
30-day PE-related mortality  9 (8.3%) 10 (4.3%) .15 
 Unknown 5 (4.3%) 7 (2.8%)  
30-day all-cause mortality  11 (10.0%) 18 (7.9%) .51 
Low-risk  0 (0.0%) 1 (3.7%)  
Intermediate-low  3 (15.8%) 5 (10.7)  
Intermediate-high  5 (9.0) 4 (4.2%)  
High  0 (0.0%) 6 (15.3%)  
Unknown  3 (27.2%) 2 (9.5%)  
FactorLevelBlack (n = 115)Other races (n = 251)P value
Demographic characteristics     
Age, mean  60.5 (15.6) 62.0 (16.1) .42 
Gender Women 60 (52.2%) 117 (46.6%) .32 
Racial group Black 115 (100.0%) 0 (0.0%) <.001 
 White 0 (0.0%) 234 (93.2%) <.001 
 Hispanic 0 (0.0%) 9 (3.6%) .04 
 Asian 0 (0.0%) 2 (0.8%) .34 
 Native American 0 (0.0%) 0 (0.0%) 
 Other 0 (0.0%) 6 (2.4%) .1 
History of heart failure  23 (22.5%) 27 (12.3%) .018 
History of chronic lung disease  23 (22.8%) 41 (18.7%) .4 
History of cancer  19 (18.6%) 75 (33.8%) .005 
Smoking  21 (22.8%) 23 (11.6%) .013 
PE and treatment characteristics     
European Society of Cardiology Risk Low 10 (8.7%) 29 (11.6%) .45 
 Intermediate-low 19 (16.5%) 51 (20.3%)  
 Intermediate-high 56 (48.7%) 97 (38.6%)  
 High 15 (13.0%) 41 (16.3%)  
 Unknown 15 (13.0%) 33 (13.1%)  
Presence of right ventricular strain by CT or echocardiography  82 (82.0%) 177 (81.6%) .99 
 Unknown 15 (13.0%) 33 (13.1%)  
Systemic thrombolysis  6 (6.6%) 16 (8.0%) .67 
Catheter directed therapy  47 (51.1%) 109 (51.7%) .93 
PE outcomes     
Length of hospital stay, median  13.8 (12.1) 14.3 (15.7) .78 
90-day major bleeding  8 (9.2%) 8 (4.3%) .11 
30-day PE-related mortality  9 (8.3%) 10 (4.3%) .15 
 Unknown 5 (4.3%) 7 (2.8%)  
30-day all-cause mortality  11 (10.0%) 18 (7.9%) .51 
Low-risk  0 (0.0%) 1 (3.7%)  
Intermediate-low  3 (15.8%) 5 (10.7)  
Intermediate-high  5 (9.0) 4 (4.2%)  
High  0 (0.0%) 6 (15.3%)  
Unknown  3 (27.2%) 2 (9.5%)  

P values were calculated using Pearson χ2 test or Fisher exact test when expected counts were <5 for categorical variables and paired t test for continuous variables. All reported P values are 2-sided, and a value of <.05 was considered significant.

For continuous variables, standard deviation is noted in parentheses. For categorical variables, percentage is noted in parentheses. For reported medians, interquartile range is noted in parentheses. ESC risk classification is based on the 2019 ESC risk of early death in PE classification.

CT, computed tomography.

Close Modal

or Create an Account

Close Modal
Close Modal